Download
s12889-021-11206-9.pdf 538,23KB
WeightNameValue
1000 Titel
  • Protocol of the Cologne Corona Surveillance (CoCoS) Study– a prospective population-based cohort study
1000 Autor/in
  1. Oberste, Max |
  2. Pusch, Lynn-Marie |
  3. Roth, Rebecca |
  4. Shah-Hosseini, Kija |
  5. Dewald, Felix |
  6. Müller, Claudia |
  7. Stach von Goltzheim, Luise |
  8. Lehmann, Clara |
  9. Buess, Michael |
  10. Wolff, Anna |
  11. Fätkenheuer, Gerd |
  12. Wiesmüller, Gerhard |
  13. Klein, Florian |
  14. Hellmich, Martin |
  15. Neuhann, Florian |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-07-02
1000 Erschienen in
1000 Quellenangabe
  • 21(1):1295
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s12889-021-11206-9 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253235/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!Surveillance strategies are critical to cope with the current SARS-CoV-2 pandemic and to evaluate, as well as adjust government-imposed countermeasures. Incidence estimates are widely based on laboratory confirmed cases reported by health authorities. Prevalence and incidence data of SARS-CoV-2 is still scarce, along with demographic and behavioural factors associated with infection risk.!##!Methods!#!The Cologne Corona Surveillance Study will be conducted in the City of Cologne, which is the fourth-largest city in Germany with a population of approximately 1.1 million. Researchers will apply self-sampling surveillance to a rolling cohort of Cologne residents. Random samples of 6000 Cologne residents 18 years of age and older will be drawn from the registration office. Upon receiving the information and saliva sample kit, participants will be asked to fill out a questionnaire online or via phone, sign written informed consent, and send back written consent, as well as saliva sample. The saliva samples will be tested for SARS-CoV-2 by reverse PCR. The questionnaire will be administered to gather information about personal characteristics such as health status and risks. A second round of testing will take place 6 weeks after the first.!##!Discussion!#!Self-administered saliva sampling proved to be a legitimate and feasible alternative to nasopharyngeal swabs taken by health professionals. However, it is unclear whether the targeted response rate of 40% can be achieved and whether the results are representative of the population.!##!Trial registration!#!DRKS.de, German Clinical Trials Register (DRKS), Identifier: DRKS00024046 , Registered on 25 February 2021.
1000 Sacherschließung
gnd 1206347392 COVID-19
lokal Adolescent [MeSH]
lokal Socio-economic factors
lokal Adult [MeSH]
lokal Study Protocol
lokal Humans [MeSH]
lokal Prospective Studies [MeSH]
lokal Treatment Outcome [MeSH]
lokal Surveillance
lokal COVID-19
lokal Risk behaviours
lokal Cohort Studies [MeSH]
lokal Coronavirus
lokal Infectious Disease epidemiology
lokal Rolling cohort
lokal COVID-19 [MeSH]
lokal Pandemic
lokal SARS-CoV-2 [MeSH]
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/T2JlcnN0ZSwgTWF4|https://frl.publisso.de/adhoc/uri/UHVzY2gsIEx5bm4tTWFyaWU=|https://frl.publisso.de/adhoc/uri/Um90aCwgUmViZWNjYQ==|https://frl.publisso.de/adhoc/uri/U2hhaC1Ib3NzZWluaSwgS2lqYQ==|https://frl.publisso.de/adhoc/uri/RGV3YWxkLCBGZWxpeA==|https://frl.publisso.de/adhoc/uri/TcO8bGxlciwgQ2xhdWRpYQ==|https://frl.publisso.de/adhoc/uri/U3RhY2ggdm9uIEdvbHR6aGVpbSwgTHVpc2U=|https://frl.publisso.de/adhoc/uri/TGVobWFubiwgQ2xhcmE=|https://frl.publisso.de/adhoc/uri/QnVlc3MsIE1pY2hhZWw=|https://frl.publisso.de/adhoc/uri/V29sZmYsIEFubmE=|https://frl.publisso.de/adhoc/uri/RsOkdGtlbmhldWVyLCBHZXJk|https://frl.publisso.de/adhoc/uri/V2llc23DvGxsZXIsIEdlcmhhcmQ=|https://frl.publisso.de/adhoc/uri/S2xlaW4sIEZsb3JpYW4=|https://orcid.org/0000-0001-5174-928X|https://frl.publisso.de/adhoc/uri/TmV1aGFubiwgRmxvcmlhbg==
1000 Hinweis
  • DeepGreen-ID: 140a5673a6884704b5683cd24c5aea23 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6462571.rdf
1000 Erstellt am 2023-11-15T13:16:34.074+0100
1000 Erstellt von 322
1000 beschreibt frl:6462571
1000 Zuletzt bearbeitet Thu Nov 30 20:05:44 CET 2023
1000 Objekt bearb. Thu Nov 30 20:05:44 CET 2023
1000 Vgl. frl:6462571
1000 Oai Id
  1. oai:frl.publisso.de:frl:6462571 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source